Clexane
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Purpose To demonstrate the pharmacokinetic/pharmacodynamic (PK/PD) equivalence of a biosimilar enoxaparin to the reference drug…
The aim of this study is to evaluate the efficiency of low‐dose, low‐molecular‐weight heparin (enoxaparin) in the treatment of…
BACKGROUND
The aim of this prospective study was to analyse the group of patients with DVT (deep vein thrombosis) treated at home…
The anticoagulants, unfractionated heparin and low‐molecular‐weight heparin, demonstrated anti‐inflammatory effects in animal…
Summary We have previously reported (Brieger D, Dawes J. Thromb Haemost 1994; 72: 275-80) that the prolonged anti-Xa amidolytic…
Summary Glycosaminoglycans (GAGs) are an important component of endothelial barrier function. Early passage human umbilical vein…
Low-dose low molecular heparin inhibits T lymphocyte-mediated autoimmune disease and allograft reactions in mice in vivo and in…
Summary It is widely reported that persistent anti-Xa activity follows administration of low molecular weight heparins. To…
The pharmacokinetics of enoxaparin (Clexane) and unfractionated heparin were compared by crossover study in healthy volunteers…
Different low molecular weight heparins have been compared with unfractionated heparin for the prevention of venous thrombosis in…